期刊文献+
共找到158篇文章
< 1 2 8 >
每页显示 20 50 100
Xenobiotic receptors in mediating the effect of sepsis on drug metabolism 被引量:3
1
作者 Chuanzhu Lv Ling Huang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2020年第1期33-41,共9页
Sepsis is an infection-induced systemic inflammatory syndrome.The immune response in sepsis is characterized by the activation of both proinflammatory and anti-inflammatory pathways.When sepsis occurs,the expression a... Sepsis is an infection-induced systemic inflammatory syndrome.The immune response in sepsis is characterized by the activation of both proinflammatory and anti-inflammatory pathways.When sepsis occurs,the expression and activity of many inflammatory cytokines are markedly affected.Xenobiotic receptors are chemical-sensing transcription factors that play essential roles in the transcriptional regulation of drug-metabolizing enzymes(DMEs).Xenobiotic receptors mediate the functional crosstalk between sepsis and drug metabolism because the inflammatory cytokines released during sepsis can affect the expression and activity of xenobiotic receptors and thus impact the expression and activity of DMEs.Xenobiotic receptors in turn may affect the clinical outcomes of sepsis.Thisreview focuses on the sepsis-induced inflammatory response and xenobiotic receptors such as pregnane X receptor(PXR),aryl hydrocarbon receptor(AHR),glucocorticoid receptor(GR),and constitutive androstane receptor(CAR),DMEs such as CYP1A,CYP2B6,CYP2C9,and CYP3A4,and drug transporters such as p-glycoprotein(P-gp),and multidrug resistance-associated protein(MRPs)that are affected by sepsis.Understanding the xenobiotic receptor-mediated effect of sepsis on drug metabolism will help to improve the safe use of drugs in sepsis patients and the development of new xenobiotic receptor-based therapeutic strategies for sepsis. 展开更多
关键词 SEPSIS Inflammatory CYTOKINES XENOBIOTIC RECEPTORS drug metabolism drug-metabolizing ENZYMES drug transporters
原文传递
Effects of Buyang Huanwu Decoction on antioxidant and drug-metabolizing enzymes in rat liver 被引量:3
2
作者 FAN Xing-Hua SHI Wei-Zhou +1 位作者 CHENG Yun-Xiang YANG Xiu-Fen 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2014年第6期449-454,共6页
AIM: To study the effect of Buyang Huanwu Decoction(BYHWD) on the antioxidant enzymes and drug-metabolizing enzymes in rat liver. METHOD: Following treatment of rats with BYHWD at 6.42, 12.83, or 25.66 g·kg–1 pe... AIM: To study the effect of Buyang Huanwu Decoction(BYHWD) on the antioxidant enzymes and drug-metabolizing enzymes in rat liver. METHOD: Following treatment of rats with BYHWD at 6.42, 12.83, or 25.66 g·kg–1 per day for 15 days, microsomes and cytosols isolated from the liver tissues were prepared by differential centrifugation according to standard procedures. The activities of the antioxidant enzymes and cytochrome b5, NADPH-cytochrome P450 reductase, CYP3 A, CYP2E1, UGT, and GST of the rat livers were determined by UV-Vis spectrophotometer. RESULTS: The activities of ALT, AST, antioxidant enzymes, and the Hepatosomatic Index in serum were not significantly affected. In cytosols, the activity of CAT was significantly increased at the dosage of 12.83 g·kg–1, and all the other antioxidant activities and MDA levels were not affected by this treatment. BYHWD had no effect on cytochrome b5, NADPH-cytochrome P450 reductase, CYP3 A, and UGT. At the highest dose(25.66 g·kg–1), the activity of CYP2E1 was significantly inhibited, and the activities of GST and the level of GSH were increased. CONCLUSION: BYHWD is safe for the liver, and has the functions of detoxification and antioxidant. Patients should be cautioned about the herb-drug interaction of BYHWD and CYP2E1 substrates. 展开更多
关键词 Buyang Huanwu Decoction ANTIOXIDANT drug-metabolizing enzymes
原文传递
Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine 被引量:1
3
作者 Shinhee Park Sunny Lihua Cheng Julia Yue Cui 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2016年第5期475-491,共17页
Intestine is responsible for the biotransformation of many orally-exposed chemicals.The constitutive androstane receptor(CAR/Nr1i3) is known to up-regulate many genes encoding drugmetabolizing enzymes and transporters... Intestine is responsible for the biotransformation of many orally-exposed chemicals.The constitutive androstane receptor(CAR/Nr1i3) is known to up-regulate many genes encoding drugmetabolizing enzymes and transporters(drug-processing genes/DPGs) in liver,but less is known regarding its effect in intestine.Sixty-day-old wild-type and Car / mice were administered the CARligand TCPOBOP or vehicle once daily for 4 days.In wild-type mice,Car m RNA was down-regulated by TCPOBOP in liver and duodenum.Car / mice had altered basal intestinal expression of many DPGs in a section-specific manner.Consistent with the liver data(Aleksunes and Klaassen,2012),TCPOBOP upregulated many DPGs(Cyp2b10,Cyp3a11,Aldh1a1,Aldh1a7,Gsta1,Gsta4,Gstm1-m4,Gstt1,Ugt1a1,Ugt2b34,Ugt2b36,and Mrp2–4) in specific sections of small intestine in a CAR-dependent manner.However,the m RNAs of Nqo1 and Papss2 were previously known to be up-regulated by TCPOBOP in liver but were not altered in intestine.Interestingly,many known CAR-target genes were highest expressed in colon where CAR is minimally expressed,suggesting that additional regulators are involved in regulating their expression.In conclusion,CAR regulates the basal expression of many DPGs in intestine,and although many hepatic CAR-targeted DPGs were bona fide CAR-targets in intestine,pharmacological activation of CAR in liver and intestine are not identical. 展开更多
关键词 drug-processing genes INTESTINE Mice CAR drug-metabolizing enzymes Transporters
原文传递
Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives 被引量:1
4
作者 Qiang Jin Jing Jing Wu +4 位作者 Yue Wu Hongxin Li Moshe Finel Dandan Wang Guangbo Ge 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第3期1068-1099,共32页
Drug-metabolizing enzymes(DMEs),a diverse group of enzymes responsible for the metabolic elimination of drugs and other xenobiotics,have been recognized as the critical determinants to drug safety and efficacy.Deciphe... Drug-metabolizing enzymes(DMEs),a diverse group of enzymes responsible for the metabolic elimination of drugs and other xenobiotics,have been recognized as the critical determinants to drug safety and efficacy.Deciphering and understanding the key roles of individual DMEs in drug metabolism and toxicity,as well as characterizing the interactions of central DMEs with xenobiotics require reliable,practical and highly specific tools for sensing the activities of these enzymes in biological systems.In the last few decades,the scientists have developed a variety of optical substrates for sensing human DMEs,parts of them have been successfully used for studying target enzyme(s)in tissue preparations and living systems.Herein,molecular design principals and recent advances in the development and applications of optical substrates for human DMEs have been reviewed systematically.Furthermore,the challenges and future perspectives in this field are also highlighted.The presented information offers a group of practical approaches and imaging tools for sensing DMEs activities in complex biological systems,which strongly facilitates high-throughput screening the modulators of target DMEs and studies on drug/herb-drug interactions,as well as promotes the fundamental researches for exploring the relevance of DMEs to human diseases and drug treatment outcomes. 展开更多
关键词 Optical substrates drug-metabolizing enzymes(DMEs) Fluorescence-based assay High-throughput screening
原文传递
Recent advance in SNP identifying methods and individualized medication 被引量:2
5
作者 彭锐 张洪 张英 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2014年第10期731-738,共8页
Polymorphisms associated with genes coding for a variety of drug-metabolizing enzymes (DMEs) and associated transport proteins can influence the drug metabolism rate of individuals, potentially affecting the efficac... Polymorphisms associated with genes coding for a variety of drug-metabolizing enzymes (DMEs) and associated transport proteins can influence the drug metabolism rate of individuals, potentially affecting the efficacy of drug and the occurrence of adverse reactions. Single nucleotide polymorphisms (SNPs) are prevalent in all types of genetic variations. Reliable SNP genotyping provides excellent markers for detecting genetic polymolphisms, genetic disorders, and resistance of pathogen to drug, which are needed for the genetic diagnosis of disease and subtle genetic factors. With a large number of SNP genotyping studies being conducted, a lot of novel SNP identifying methods have been developed. Several SNP genotyping methods and techniques have been introduced for clinical test. These include TaqMan drug metabolism genotyping assays, pH-sensing semiconductor system, high-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons, novel multiplexed electrochemical biosensor with non-fouling surface, DNA hybridization detection using less than 10-nm gap silicon nanogap structure, tetra-primer ARMS-PCR method, acoustic detection of DNA conformation in genetic assays combined with PCR, microbeads-mass spectrometry (MEMS)-based approach, and liquid chromatography-electrospray ionization mass spectrometry. Personalized medicine has changed the conventional ways of using drugs according to experiences. It focuses on making the individualized pattern for each individual based on their own characteristics. Lots of researchers are using the analysis of clinical samples to explain the relationship between the drug adverse reactions and genetic polymorphisms. But it takes a long time from collecting the blood samples for DNA extraction and genotyping to getting results on the side effect of drug through clinical study. Therefore, it is desirable to develop improved in vitro methods to study the drug metabolizing-enzymes and transport protein genetic polymorphisms. 展开更多
关键词 Single nucleotide polymorphism GENOTYPING drug-metabolizing enzymes Transporters PHARMACOGENOMICS
原文传递
Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice
6
作者 Pei Wang Xueyan Shao +5 位作者 Yifan Bao Junjie Zhu Liming Chen Lirong Zhang Xiaochao Ma Xiao-bo Zhong 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2020年第1期171-185,共15页
The prevalence of obesity-associated conditions raises new challenges in clinical medication.Although altered expression of drug-metabolizing enzymes(DMEs)has been shown in obesity,the impacts of obese levels(overweig... The prevalence of obesity-associated conditions raises new challenges in clinical medication.Although altered expression of drug-metabolizing enzymes(DMEs)has been shown in obesity,the impacts of obese levels(overweight,obesity,and severe obesity)on the expression of DMEs have not been elucidated.Especially,limited information is available on whether parental obese levels affect ontogenic expression of DMEs in children.Here,a high-fat diet(HFD)and three feeding durations were used to mimic different obese levels in C57BL/6 mice.The hepatic expression of five nuclear receptors(NRs)and nine DMEs was examined.In general,a trend of induced expression of NRs and DMEs(except for Cyp2c29 and 3a11)was observed in HFD groups compared to low-fat diet(LFD)groups.Differentialeffects of HFD on the hepatic expression of DMEs were found in adult mice at different obese levels.Family-based dietary style of an HFD altered the ontogenic expression of DMEs in the offspring older than 15 days.Furthermore,obese levels of parental mice affected the hepatic expression of DMEs in offspring.Overall,the results indicate that obese levels affected expression of the DMEs in adult individuals and that of their children.Drug dosage might need to be optimized based on the obese levels. 展开更多
关键词 Diet-induced obesity OVERWEIGHT HIGH-FAT DIET drug-metabolizing enzymes Nuclear RECEPTORS Ontogenic EXPRESSION
原文传递
Mutagenicity and Induction of Drug-metabolizing Enzyme Activity by LPG Combustion Particulates in Rats
7
作者 YIN XUE-JUN LIU JUN-ZHUO +3 位作者 LI YONG-SHUN KONG XIANG-HUAN AND LIU HONG(Department of Environmental Health, Capital University of Medical Sciences, Beijing 100054, China Department of Environmental Health, Beijing Medical University, Beijing, China) 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 1994年第4期346-356,共11页
Methylene chloride extracts of particulates from liquefied petroleum gas (LPG) combustion appliance were studied by using Ames test, micronucleus test and inducibility of pulmonary and hepatic aryl hydrocarbon hydroxy... Methylene chloride extracts of particulates from liquefied petroleum gas (LPG) combustion appliance were studied by using Ames test, micronucleus test and inducibility of pulmonary and hepatic aryl hydrocarbon hydroxylase (AHH) and glutathione S-transferase (GST) in rats. The extracts showed mutagenicity for Salmonella typhimurium strain TA98 and its derivatives TA98NR and TA98/1,8-DNP6 with or without S9 mix. The revertants in strains TA98NR and TA98/1,8-DNP6 were less than 40% and 50% of that in strain TA98 without S9 mix, respectively. Positive results were obtained in mouse bone marrow micronucleus assay. Intratracheal instillation of the extracts led to increase in pulmonary (but not hepatic) AHH and GST activities in rats. It was seen that AHH was more sensitive than GST to induction by the extracts 展开更多
关键词 ACTIVITY Mutagenicity and Induction of drug-metabolizing Enzyme Activity by LPG Combustion Particulates in Rats DNP LPG
下载PDF
黄酮类化合物的药物代谢研究进展 被引量:53
8
作者 何佳珂 于洋 +4 位作者 陈西敬 孙伟 方芳 李宁 郑剑恒 《中国中药杂志》 CAS CSCD 北大核心 2010年第21期2789-2794,共6页
黄酮类化合物是食物和传统中药中所含的一类重要的天然植物成分。大多数黄酮具有很强的还原活性故在体内易被氧化代谢,该过程通常由CYP1A酶家族参与。此外,某些甲氧基黄酮在体内还可进行脱甲基代谢;黄酮类化合物的分子结构中往往含有1... 黄酮类化合物是食物和传统中药中所含的一类重要的天然植物成分。大多数黄酮具有很强的还原活性故在体内易被氧化代谢,该过程通常由CYP1A酶家族参与。此外,某些甲氧基黄酮在体内还可进行脱甲基代谢;黄酮类化合物的分子结构中往往含有1个或多个酚羟基,易和葡萄糖醛酸、硫酸或谷胱甘肽等结合,生成水溶性较大的化合物排出体外;天然黄酮类化合物多以苷类形式存在,口服后易被肠道菌群产生的水解酶代谢为苷元再吸收入血。不少黄酮类化合物对CYP酶有较强的抑制作用,该作用是某些黄酮类化合物预防和抑制肿瘤的重要机制之一。该文总结了黄酮类化合物药物代谢的特点,并对黄酮类化合物和CYP酶的代谢相互作用进行了综述。 展开更多
关键词 黄酮类化合物 药物代谢 药物代谢酶 药物相互作用
原文传递
五味子酯甲对肝脏药物代谢酶的调节及药理作用的研究进展 被引量:17
9
作者 付亚东 陈佳美 +1 位作者 刘伟 刘平 《中药新药与临床药理》 CAS CSCD 北大核心 2020年第6期741-748,共8页
五味子为木兰科植物五味子(北五味子)及华中五味子(南五味子)的干燥成熟果实,其药用价值高且临床应用广泛,是中医药处方配伍常用药材之一。五味子酯甲(Schisantherin A,SA)是五味子的主要活性成分和效应物质基础,其参与调节体内药物代谢... 五味子为木兰科植物五味子(北五味子)及华中五味子(南五味子)的干燥成熟果实,其药用价值高且临床应用广泛,是中医药处方配伍常用药材之一。五味子酯甲(Schisantherin A,SA)是五味子的主要活性成分和效应物质基础,其参与调节体内药物代谢,SA的体内代谢具有血药浓度达峰快(Tmax为1 h左右)、半衰期较长(t1/2为12 h左右)、口服生物利用度较低(F为4%左右)、易受CYP450酶影响、存在性别差异等特点,通过影响肝脏药物代谢酶(CYP450、UGTs和ADH/ALDH等)活性在组织、细胞水平调节体内药物代谢过程及存在潜在的药物-药物相互作用。SA的药理作用主要表现在抗炎性损伤、抗氧化应激和器官保护等方面,此外,还具有镇静催眠、抗疲劳、抑制血管新生等作用,其主要的效应机制有调控NF-κB、MAPK、Caspase途径以及ERK/Nrf2、PI3K/AKT信号通路等。 展开更多
关键词 五味子酯甲 肝脏药物代谢酶 药物代谢 药物-药物相互作用 药理作用 研究进展
原文传递
依诺沙星对大鼠肝药酶的抑制作用 被引量:13
10
作者 莫岚 钱元恕 +1 位作者 王其南 兰雁飞 《中国抗生素杂志》 CAS CSCD 北大核心 1995年第5期384-388,共5页
在肝微粒体水平上,采用依诺沙里400mg/kg,灌胃qd×7d能显著减少大鼠肝微粒体细胞色素P450。含量,经依诺沙星处理的大鼠肝微粒体中氨基比林-N-脱甲基酶、NADPH-细胞色素C还原酶、7-乙氧基香豆素-O... 在肝微粒体水平上,采用依诺沙里400mg/kg,灌胃qd×7d能显著减少大鼠肝微粒体细胞色素P450。含量,经依诺沙星处理的大鼠肝微粒体中氨基比林-N-脱甲基酶、NADPH-细胞色素C还原酶、7-乙氧基香豆素-O-脱乙基酶、苯并芘羟化酶、戊巴比妥侧链羟化酶的活性均显著减弱。可见,依诺沙星对大鼠肝药酶具有广泛的抑制作用。 展开更多
关键词 依诺沙星 肝微粒体 肝药酶 酶抑制剂
下载PDF
河南地区汉族人群药物代谢酶CYP2C19,NAT2和TPMT基因多态性分析(英文) 被引量:11
11
作者 张莉蓉 张伟 +3 位作者 阴振坤 赵峻 贾琳静 宋东奎 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第8期561-566,共6页
目的:了解细胞色素P450(cytochromes P450,CYP)2C19,N-乙酰基转移酶2(arylamine N- acetyltransferase 2,NAT2)和硫嘌呤甲基转移酶(thiopurine S-methyltransferase,TPMT)基因常见的遗传多态性在河南地区汉族人群中的分布及其频率。方... 目的:了解细胞色素P450(cytochromes P450,CYP)2C19,N-乙酰基转移酶2(arylamine N- acetyltransferase 2,NAT2)和硫嘌呤甲基转移酶(thiopurine S-methyltransferase,TPMT)基因常见的遗传多态性在河南地区汉族人群中的分布及其频率。方法:应用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)对210名河南地区汉族人群的CYP2C19突变基因(*2和*3)、NAT2突变基因(*6和*7)和TPMT突变基因(*3A,*3B和*3C)进行检测。用聚合酶链反应-等位基因特异性扩增(PCR-ASA)对NAT2突变基因(*5)和TPMT突变基因(*2)进行检测。结果:CYP2C19*2和*3等位基因分布频率分别为34.76%和6.4%,同时携带2个等位突变基因的慢基因型频率占14.8%。NAT2*4(wt),*5(341C),*6(590A)和*7(857A)等位基因分布频率分别为59.1%,4.1%,26.4%和9.5%,慢基因型分布频率占19.5%。TPMT*3C等位基因分布频率为1.2%,未发现TPMT*2,TPMT*3A或TPMT*3B。结论:CYP2C19,NAT2和TPMT基因常见的遗传多态性在汉族人群中的分布及其频率与白人存在明显差异,这将有助于我国汉族人群临床药动学研究和给药剂量的确定。 展开更多
关键词 代谢 酶类 多态现象(遗传学) 药物代谢酶 汉族
下载PDF
粗叶悬钩子粗多糖对模型大鼠急性肝损伤药物代谢酶的影响 被引量:11
12
作者 刘艳 李天骄 +1 位作者 赵锦燕 洪振丰 《福建中医学院学报》 2008年第2期13-15,共3页
目的观察粗叶悬钩子粗多糖对模型大鼠急性肝损伤药物代谢酶的影响。方法用四氯化碳(CCl4)腹腔注射法造模,观察粗叶悬钩子粗多糖对大鼠血清谷丙转氨酶(ALT)、谷草转氨酶(AST)和大鼠肝组织CYP450、CYP2E1、CYP3A1酶含量与活性变化。结果与... 目的观察粗叶悬钩子粗多糖对模型大鼠急性肝损伤药物代谢酶的影响。方法用四氯化碳(CCl4)腹腔注射法造模,观察粗叶悬钩子粗多糖对大鼠血清谷丙转氨酶(ALT)、谷草转氨酶(AST)和大鼠肝组织CYP450、CYP2E1、CYP3A1酶含量与活性变化。结果与CCl4模型组相比,粗叶悬钩子粗多糖治疗各组均不同程度地降低了CCl4所致大鼠ALT、AST的升高;不同程度地增高了肝药物代谢CYP450含量及活性,降低了CYP2E1含量及活性,对CYP3A1含量及活性的影响无统计学意义。结论粗叶悬钩子粗多糖通过改变肝药物代谢酶保护CCl4所致的大鼠急性肝损伤。 展开更多
关键词 粗叶悬钩子 粗多糖 大鼠模型 急性肝损伤 肝药物代谢酶 CYP450 CYP2E1 CYP3A1
下载PDF
核受体对药物代谢酶和转运体的调控 被引量:9
13
作者 刘志浩 李燕 《药学学报》 CAS CSCD 北大核心 2012年第12期1575-1581,共7页
PXR、CAR和PPAR是核受体家族的重要成员,体内分布广泛,经配体激活后可调控药物代谢酶及转运体的表达和活性,影响药物在体内的处置。肿瘤多药耐药是导致癌症治疗失败的主要原因,核受体对药物代谢过程产生的影响可能使其成为逆转肿瘤多药... PXR、CAR和PPAR是核受体家族的重要成员,体内分布广泛,经配体激活后可调控药物代谢酶及转运体的表达和活性,影响药物在体内的处置。肿瘤多药耐药是导致癌症治疗失败的主要原因,核受体对药物代谢过程产生的影响可能使其成为逆转肿瘤多药耐药的新药作用靶点。本文主要介绍了核受体家族主要成员PXR、CAR和PPAR的研究进展,阐述其转录激活机制以及其对药物代谢酶及转运体的调控,为临床合理用药、克服肿瘤多药耐药的研究等提供参考。 展开更多
关键词 核受体 代谢酶 膜转运蛋白 多药耐药
原文传递
肝损伤大鼠肝脏异物代谢功能的改变 被引量:9
14
作者 汪晖 陈曼 廖长秀 《中国药理学通报》 CAS CSCD 北大核心 2004年第7期772-775,共4页
目的 研究不同肝损伤状态下肝脏药物代谢和抗氧化功能的变化及规律 ,为肝纤维化患者的临床合理用药提供依据。方法 建立大鼠四氯化碳急性肝损伤和复合因素肝纤维化、肝硬化模型 ,差速离心法制备肝亚细胞组分 ,测定药物代谢酶和抗氧化... 目的 研究不同肝损伤状态下肝脏药物代谢和抗氧化功能的变化及规律 ,为肝纤维化患者的临床合理用药提供依据。方法 建立大鼠四氯化碳急性肝损伤和复合因素肝纤维化、肝硬化模型 ,差速离心法制备肝亚细胞组分 ,测定药物代谢酶和抗氧化酶活性。结果 不同肝损伤状态下大鼠肝微粒体药物代谢Ⅰ相酶———细胞色素P4 5 0 (CYP)总量、CYP1A1、3A活性和Ⅱ相酶—谷胱甘肽S 转移酶 (GST)活性均明显降低 ,随损伤时间递减 ,在肝硬化时达最低 ;而CYP2E1活性在急性肝损伤时即达最低 ,随染毒时间的延长而有所恢复。肝纤维化状态下CYP1A、CYP2E1、CYP3A和GST活性分别为正常对照组的 6 8%、5 6 %、81%和 5 9%。肝纤维化状态下胞浆抗氧化酶 GST、过氧化氢酶和谷胱甘肽过氧化物酶活性也呈不同程度降低 ,为正常对照组的 85 %、76 %和 5 4 %。结论 肝纤维化时 ,肝脏异物代谢酶功能降低 ,其降低程度多与肝损伤轻重和时间长短有关。 展开更多
关键词 肝纤维化 药物代谢酶 抗氧化酶
下载PDF
慢性肾衰竭对非肾消除药物体内代谢与转运的影响 被引量:7
15
作者 李辉 芮建中 《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第21期2179-2181,共3页
慢性肾衰竭降低药物肾清除率的同时,还会干扰正常的体内代谢过程,多种药物代谢酶、转运体的表达量、活性等均会发生改变。肠道内药物外排减少、代谢降低增加了药物的生物利用度,而肝内摄取转运体减少、外排转运体增多则降低了细胞内药... 慢性肾衰竭降低药物肾清除率的同时,还会干扰正常的体内代谢过程,多种药物代谢酶、转运体的表达量、活性等均会发生改变。肠道内药物外排减少、代谢降低增加了药物的生物利用度,而肝内摄取转运体减少、外排转运体增多则降低了细胞内药物浓度,并放大代谢酶减少所导致的非肾清除率降低,使得华法林等治疗窗窄的药物出血风险增大。因此,慢性肾衰竭患者除合理调整主要经肾消除药物外,还需关注非肾消除药物的用药剂量。本文对慢性肾衰竭影响药物体内代谢、转运过程进行分析,为临床个体化调整非肾消除药物剂量提供理论基础。 展开更多
关键词 慢性肾衰竭 药物代谢酶 药物转运体 合理用药
原文传递
雌激素对老年雌性去势大鼠肝脏代谢能力及抗氧化功能的影响 被引量:8
16
作者 张韶英 平洁 汪晖 《中国临床药理学与治疗学》 CAS CSCD 2005年第4期424-427,共4页
目的:观察老年雌性去势大鼠补充乙烯雌酚后肝脏药物代谢酶活性及抗氧化功能的变化,并探讨更年期应用雌激素的生理学和药理学意义。方法:切除大鼠双侧卵巢造成雌激素锐减。术后d 3经口灌胃乙烯雌酚(10 0 μg·kg- 1,qd×4 0d) ,... 目的:观察老年雌性去势大鼠补充乙烯雌酚后肝脏药物代谢酶活性及抗氧化功能的变化,并探讨更年期应用雌激素的生理学和药理学意义。方法:切除大鼠双侧卵巢造成雌激素锐减。术后d 3经口灌胃乙烯雌酚(10 0 μg·kg- 1,qd×4 0d) ,每天1次,连续4 0d。观察大鼠肝脏药物代谢酶活性和抗氧化指标的变化。结果:去势大鼠肝微粒体细胞色素P4 5 0及细胞色素b5含量显著降低,NADPH 细胞色素C还原酶、苄非他明N 脱甲基酶、氨基比林N 脱甲基酶活性也明显降低。肝微粒体及肝匀浆中谷胱甘肽S 转移酶活性显著降低,肝匀浆谷胱甘肽含量减少,脂质过氧化产物丙二醛增加。给予乙烯雌酚后,除对细胞色素b5无明显影响外,上述指标均可逆转。结论:老年雌性大鼠去势后肝脏代谢能力及抗氧化功能的降低与雌激素水平低下有关。乙烯雌酚能有效地改善上述变化,维持肝脏正常的代谢能力及抗氧化功能。 展开更多
关键词 去势 大鼠 雌激素 药物代谢功能 抗氧化功能
下载PDF
肠道“药物代谢酶-外排转运体偶联”对黄酮类化合物生物利用度影响的研究进展 被引量:7
17
作者 师少军 《中国医院药学杂志》 CAS 北大核心 2019年第20期2107-2112,共6页
黄酮类化合物为广泛存在于食物和药物中的一类多酚化合物,具有多种药理作用,但其生物利用度低限制了其临床应用,这与其肠道吸收和代谢密切相关。黄酮类化合物主要在肠道吸收,并经Ⅱ相药物代谢酶:葡萄糖醛酸转移酶(UGTs),硫酸转移酶(SUL... 黄酮类化合物为广泛存在于食物和药物中的一类多酚化合物,具有多种药理作用,但其生物利用度低限制了其临床应用,这与其肠道吸收和代谢密切相关。黄酮类化合物主要在肠道吸收,并经Ⅱ相药物代谢酶:葡萄糖醛酸转移酶(UGTs),硫酸转移酶(SULTs)和谷胱甘肽-S-转移酶(GSTs)广泛代谢为Ⅱ相代谢产物,其极性增加,难以通过被动扩散穿透肠上皮细胞膜。肠道外排转运体P-糖蛋白(P-gp)、乳腺癌耐药蛋白(BCRP)、多药耐药相关蛋白(MRPs)作为一个"旋转门",可调控肠上皮细胞内Ⅱ相代谢物外排至肠腔或进入体循环。本文对黄酮类化合物在肠道处置以及肠道药物代谢酶-外排转运体偶联进行了探究,这种偶联作用可显著影响黄酮类化合物生物利用度,进而影响其临床疗效与毒副作用。阐明肠道代谢酶-外排转运体偶联作用及其机制,将为提高黄酮类化合物体内生物利用度和增加其临床疗效奠定基础。 展开更多
关键词 黄酮类化合物 生物利用度 肠道 药物代谢酶 外排转运体 偶联作用
原文传递
基于药物代谢酶的附子配伍减毒研究进展 被引量:1
18
作者 王婧 李星雨 +1 位作者 陈思凯 卫培峰 《中药药理与临床》 CAS CSCD 北大核心 2024年第5期97-102,共6页
附子为毛茛科多年生草本植物乌头Aconitum carmichaeli Debx.的子根加工品,具有回阳救逆、散寒止痛、温阳化气的功效,在我国有着悠久的历史和独特的应用体系。由于附子存在“效毒二重性”,当过量服用和配伍不当时,其中所含的二萜类生物... 附子为毛茛科多年生草本植物乌头Aconitum carmichaeli Debx.的子根加工品,具有回阳救逆、散寒止痛、温阳化气的功效,在我国有着悠久的历史和独特的应用体系。由于附子存在“效毒二重性”,当过量服用和配伍不当时,其中所含的二萜类生物碱会对机体的心脏和神经系统造成严重的损坏,但其潜在机制是否与肝脏药物代谢酶的代谢相互作用有关仍不明确。本文从肝脏药物代谢酶角度阐述附子活性成分的代谢特性及其配伍对药物代谢酶的亲和作用和机制,扩大附子的用药范围,降低毒副作用,促进附子合理开发和临床安全应用,以期为附子配伍减毒增效研究提供创新思路及其合理有效应用提供参考。 展开更多
关键词 附子 药物代谢酶 CYP450 配伍 减毒
原文传递
m^(6)A修饰对药物代谢酶和药物转运体的调控作用
19
作者 赵世宇 刘帅兵 +1 位作者 王月琴 田鑫 《中国药理学通报》 CAS CSCD 北大核心 2024年第7期1221-1225,共5页
m^(6)A修饰是RNA甲基化修饰中最丰富的一种修饰,受甲基转移酶和去甲基化酶的动态调控,被m^(6)A识别蛋白识别并结合后可影响mRNA的剪切、稳定性和翻译等生物学过程来调控靶基因的表达。最近的研究发现,m^(6)A修饰可通过多种途径来调控药... m^(6)A修饰是RNA甲基化修饰中最丰富的一种修饰,受甲基转移酶和去甲基化酶的动态调控,被m^(6)A识别蛋白识别并结合后可影响mRNA的剪切、稳定性和翻译等生物学过程来调控靶基因的表达。最近的研究发现,m^(6)A修饰可通过多种途径来调控药物代谢酶和药物转运体表达,进而影响机体对药物的代谢速率或影响细胞中的药物浓度,最终导致药物治疗效果发生变化。该文综述了m^(6)A修饰调控药物代谢酶和药物转运体分子机制的研究进展,以期为临床上的合理用药、个体化用药提供新思路。 展开更多
关键词 RNA甲基化 m^(6)A修饰 药物代谢酶 药物转运体 调控机制 研究进展
下载PDF
中药对药物代谢酶的影响 被引量:5
20
作者 卢新建 《齐鲁药事》 2008年第6期361-363,共3页
药物代谢酶在众多中西药物代谢中起着非常重要的作用.本文综述了近年来国内外学者就中药对药物代谢酶影响的研究思路、方法和进展.通过深入研究中药对药物代谢酶活性的影响,有利于中药基础理论的深入和发展;临床上应该重视中药与其他药... 药物代谢酶在众多中西药物代谢中起着非常重要的作用.本文综述了近年来国内外学者就中药对药物代谢酶影响的研究思路、方法和进展.通过深入研究中药对药物代谢酶活性的影响,有利于中药基础理论的深入和发展;临床上应该重视中药与其他药物合用时所发生的代谢性相互作用,优化给药方案,从而提高临床用药的有效性和安全性. 展开更多
关键词 药物代谢酶 细胞色素P450酶 中药 药物相互作用
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部